Search hospitals > Missouri > Kansas City
Research Medical Center
Claim this profileKansas City, Missouri 64132
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Cancer
Conducts research for Ovarian Cancer
296 reported clinical trials
7 medical researchers
Summary
Research Medical Center is a medical facility located in Kansas City, Missouri. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Ovarian Cancer and other specialties. Research Medical Center is involved with conducting 296 clinical trials across 406 conditions. There are 7 research doctors associated with this hospital, such as Dhanunjaya Lakkireddy, Suman Kambhampati, Rakesh Gaur, and Naga Venkata K. Pothineni, MD.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
2Lung Cancer
Global LeaderStage II
Stage I
Stage III
Top PIs
Dhanunjaya LakkireddyKansas City Cardiac Arrhythmia Research Foundation3 years of reported clinical research
Expert in Atrial Fibrillation
Studies Stroke
31 reported clinical trials
34 drugs studied
Suman KambhampatiResearch Medical Center6 years of reported clinical research
Studies Multiple Myeloma
Studies Acute Myelogenous Leukemia
16 reported clinical trials
33 drugs studied
Rakesh GaurResearch Medical Center10 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
7 reported clinical trials
22 drugs studied
Naga Venkata K. Pothineni, MDResearch Medical Center Clinic2 years of reported clinical research
Studies Atrial Fibrillation
Studies Hemostasis
5 reported clinical trials
3 drugs studied
Clinical Trials running at Research Medical Center
Breast Cancer
Lung Cancer
Breast cancer
Atrial Fibrillation
Multiple Myeloma
Brain Tumor
Cardiotoxicity
ALK Gene Rearrangement
Gliosarcoma
Glioblastoma
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This trial has two cohorts of patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. All patients must be receiving trastuzumab-based treatment. Both cohorts are being observed for cardiac toxicity. The largest cohort (currently open to accrual) is observational, and contains patients who are taking a beta blocker, ACE inhibitor, or ARB as well as their trastuzumab-based treatment. The goal is to understand how common cardiac problems are in this group of patients at high risk. The smaller cohort (currently closed to accrual) is randomized. Patients in this second cohort are randomized to either carvedilol or no treatment, with the goal of seeing whether carvedilol (used to treat heart failure and high blood pressure) may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Registry
for Breast Cancer and BRCA Mutations
PROGECT is a registry for patients with Triple Negative breast cancer (TNBC) or patients who have an identified germline mutations (such as a mutation on the BRCA1 or BRCA2 genes).
Recruiting1 award N/A10 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Research Medical Center?
Research Medical Center is a medical facility located in Kansas City, Missouri. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Ovarian Cancer and other specialties. Research Medical Center is involved with conducting 296 clinical trials across 406 conditions. There are 7 research doctors associated with this hospital, such as Dhanunjaya Lakkireddy, Suman Kambhampati, Rakesh Gaur, and Naga Venkata K. Pothineni, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.